Light Grey
covid treatment



To learn how to manage your symptoms at home, click here


When should you seek medical help? 

If you show any of these emergency warning signs, seek medical help immediately:   

  • Trouble breathing  

  • Persistent pain or pressure in the chest  

  • New confusion  

  • Inability to arouse or stay awake

  • Pale, gray, or blue-colored skin, lips, or nail beds, depending on skin tone. 

*This list is not all possible symptoms.

Please call your medical provider for any other symptoms that are severe or concerning to you. Call 911 or call ahead to your local emergency facility. Notify the operator that you are seeking care for someone who has or may have COVID-19. 



Out-of-Hospital Treatment Options for COVID-19 

Oral Antiviral Treatments 

The FDA authorized two oral antivirals, Pfizer's Paxlovid and Merck's molnupiravir, for the treatment of COVID-19 in certain patients. 

Monoclonal Antibody Treatments

COVID-19 monoclonal antibody therapeutics (mAb) are available for people ages 12 years or older who: 

  • Have tested positive for COVID-19 and have had symptoms for 7 days or less 

  • Are at high risk of becoming seriously ill, including those who have been recently exposed to someone who tested positive for COVID-19. 


  • Anyone who tests positive for COVID-19 AND has mild to moderate symptoms. See your health care provider to determine if you are eligible for the treatment. Your health care provider will need to verify and confirm your positive test result. 


  • See your health care provider for a treatment prescription and referral to a North Dakota health care facility that provides monoclonal antibody treatment.  

  • For more information on locating monoclonal antibody therapeutics, visit the Department of Health and Human Services (HHS) website here.


Hospital Treatments for COVID-19 

There are treatments for hospitalized patients with severe cases of COVID-19 that have been approved or authorized for emergency use by the Food and Drug Administration (FDA). 

  • Remdesivir is an antiviral drug approved by the FDA for the treatment of COVID-19 in hospitalized adults and hospitalized pediatric patients at least 12 years of age and weighing at least 40 pounds. It works by stopping SARS-CoV-2 from spreading in the body. 

  • The FDA has authorized additional treatments for emergency use, including convalescent plasma and other treatment combinations. 

  • Health care providers and scientists are investigating other drugs and treatments that may slow or reduce the virus’ growth and spread in the body, as well as to enhance breathing, provide disease-fighting antibodies, and help with other symptoms.